1. A structural biology view of target drugability;Egner U.;Expert Opin. Drug Discov.,2008
2. Recent advances in physicochemical and ADMET profiling in drug discovery;Wang J.;Chem. Biodivers.,2009
3. Improving lead generation success through integrated methods: transcending ‘drug discovery by numbers’;Campbell J.B.;IDrugs,2010
4. Lessons learned from candidate drug attrition;Empfield J.R.;IDrugs,2010
5. Lessons learned from the fate of AstraZeneca's drug pipeline: a five‐dimensional framework;Cook D.;Nat. Rev. Drug Discov.,2014